| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.1M | -55.7% |
| Cost of Revenue | $41K | -99.5% |
| R&D Expense | $40.7M | -42.5% |
| SG&A Expense | $28.2M | -30.7% |
| Operating Income | -$66.8M | +42.0% |
| Income Tax | $0 | — |
| Net Income | -$62.0M | +45.1% |
| EPS (Basic) | -$34.12 | -704.7% |
| EPS (Diluted) | -$34.12 | -704.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $76.7M | -41.1% |
| Accounts Receivable | $50K | -83.8% |
| Current Assets | $77.7M | -41.7% |
| Total Assets | $94.7M | -44.1% |
| Current Liabilities | $8.8M | -30.8% |
| Total Liabilities | $25.6M | -39.9% |
| Stockholders' Equity | $69.1M | -45.5% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$53.2M | +46.8% |
| Capital Expenditures | $486K | -69.9% |
| Investing Cash Flow | -$486K | +69.9% |
| Financing Cash Flow | $33K | -91.9% |
| Free Cash Flow | -$53.7M | +47.2% |